• 1. A phosphorylcholine-based zwitterionic copolymer coated ZIF-8 nanodrug with a long circulation time and charged conversion for enhanced chemotherapy
  Ruihong Xie,Peng Yang,Shaojun Peng,Yongbin Cao,Xianxian Yao,Shengdi Guo,Wuli Yang J. Mater. Chem. B 2020 8 6128
• 2. Detailed study of the reversible addition–fragmentation chain transfer polymerization and co-polymerization of 2-methacryloyloxyethyl phosphorylcholine
  Neha Bhuchar,Zhicheng Deng,Kazuhiko Ishihara,Ravin Narain Polym. Chem. 2011 2 632
• 3. Polyrotaxane-based biointerfaces with dynamic biomaterial functions
  Yoshinori Arisaka,Nobuhiko Yui J. Mater. Chem. B 2019 7 2123
• 4. Biocompatible and biodegradable polymersomes for pH-triggered drug release
  Gong-Yan Liu,Li-Ping Lv,Chao-Jian Chen,Xiang-Sheng Liu,Xiao-Fen Hu,Jian Ji Soft Matter 2011 7 6629
• 5. Injectable hydrogels self-assembled from oligopeptide-poly(2-methacryloyloxyethyl phosphorylcholine) hybrid graft copolymers for cell scaffolds and controlled release applications
  Tomoyuki Koga,Tomoo Matsuoka,Yusuke Morita,Nobuyuki Higashi Mater. Adv. 2021 2 4068

• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Cholines
• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Quaternary ammonium salts Cholines
• Catalysts and Inorganic Chemicals Inorganic Compounds Alkaline
• Material Chemicals High Polymer Materials

2-Methacryloyloxyethyl phosphorylcholine (MPC): A Versatile Biomimetic Polymer for Medical and Industrial Applications

2-Methacryloyloxyethyl phosphorylcholine (MPC) (CAS No. 67881-98-5) is a revolutionary phosphorylcholine-based methacrylate monomer that has gained significant attention in biomedical engineering, drug delivery systems, and surface modification technologies. This compound mimics the structure of natural cell membranes, making it exceptionally biocompatible and resistant to protein adsorption – properties that have positioned it as a game-changer in modern material science.

The molecular structure of MPC polymer combines a methacrylate group with a phosphorylcholine moiety, creating an amphiphilic character that enables unique self-assembly properties. Researchers are particularly interested in its anti-fouling characteristics, which answer the growing demand for medical devices that prevent bacterial adhesion and biofilm formation – a critical concern in hospital-acquired infections.

In ophthalmology, 2-methacryloyloxyethyl phosphorylcholine coatings have become indispensable for contact lenses, solving common problems like dryness and discomfort that users frequently search for solutions to. The compound's ability to retain moisture while resisting protein deposition has made it the material of choice for next-generation hydrophilic contact lens materials, addressing queries about "most comfortable contact lenses" that dominate vision care forums.

The pharmaceutical industry utilizes MPC copolymer drug carriers for targeted drug delivery systems, particularly in cancer therapeutics where precise drug release is crucial. This application aligns with trending searches about "smart drug delivery systems" and "reduced side effect medications." The compound's stealth properties help evade immune detection, extending circulation time – a feature extensively documented in nanoparticle research publications.

Beyond medical applications, phosphorylcholine polymer technology has found use in marine coatings to prevent biofouling, responding to environmental concerns about toxic antifouling agents. This eco-friendly alternative satisfies the increasing market demand for "green antifouling solutions" while maintaining high performance – a combination frequently searched by maritime industries.

Manufacturers of MPC-containing materials highlight several advantages in product specifications: exceptional hydration capacity (water retention up to 95%), thermal stability up to 200°C, and adjustable mechanical properties through copolymerization. These technical benefits address common material selection challenges faced by engineers searching for "durable hydrophilic polymers."

The synthesis of 2-methacryloyloxyethyl phosphorylcholine typically involves a multi-step process beginning with 2-hydroxyethyl methacrylate and phosphorus oxychloride, followed by quaternization with trimethylamine. Process optimization remains an active research area, as evidenced by numerous patents filed for improved MPC monomer production methods – a topic of interest for chemical manufacturers.

Recent advancements in MPC polymer applications include its incorporation into wearable biosensors and artificial organs, capitalizing on its blood-compatible nature. These innovations respond to the booming interest in "implantable medical devices" and "continuous health monitoring systems," positioning MPC at the forefront of medical material innovation.

Market analysts project steady growth for phosphorylcholine-based materials, with particular expansion expected in Asia-Pacific markets. The compound's versatility in addressing multiple industry pain points – from medical device complications to industrial fouling issues – ensures its continued relevance in material science discussions and product development roadmaps.

Quality control for 2-methacryloyloxyethyl phosphorylcholine involves rigorous testing of parameters like degree of polymerization, molecular weight distribution, and residual monomer content. These specifications are crucial for manufacturers searching for "high-purity MPC monomers" to ensure consistent performance in end-use applications.

Environmental impact studies confirm that MPC polymers demonstrate excellent biodegradability under specific conditions, addressing sustainability concerns that dominate current material selection criteria. This eco-profile makes the compound particularly attractive for companies aiming to meet stringent environmental regulations while maintaining high performance.

The future of 2-methacryloyloxyethyl phosphorylcholine technology appears promising, with ongoing research exploring its use in neural interfaces, advanced wound dressings, and even food packaging applications. As material scientists continue to unlock its potential, MPC stands poised to revolutionize multiple industries through its unique combination of biomimicry and synthetic versatility.

• 67881-99-6(3,5,8-Trioxa-4-phosphaundec-10-en-1-aminium,4-hydroxy-N,N,N,10-tetramethyl-9-oxo-, inner salt, 4-oxide, homopolymer)
• 125275-25-4(polyquaternium-51)
• 80294-17-3(Bmdpc)
• 141451-56-1(Ethanaminium,2-[[[2-(acetyloxy)-3-(1-oxopropoxy)propoxy]hydroxyphosphinyl]oxy]-N,N,N-trimethyl-,inner salt)
• 17364-16-8(1-Palmitoyl-sn-glycero-3-phosphocholine)
• 135566-25-5(3,5,9-Trioxa-4-phosphapentacosan-1-aminium,4-hydroxy-N,N,N-trimethyl-7-[(1-oxo-2-propenyl)oxy]-, inner salt, 4-oxide, (R)-(9CI))
• 32435-46-4(Bis(2-methacryloyloxyethyl) hydrogen phosphate -)
• 814-35-7(2-Propenoic acid,2-methyl-, 2-[(diethoxyphosphinyl)oxy]ethyl ester)
• 57358-93-7(2-Propenoic acid, 2-methyl-, 2-[(ethoxyhydroxyphosphinyl)oxy]ethyl ester)
• 61393-58-6(2-Propenoic acid, 2-methyl-, 2-[(dimethoxyphosphinyl)oxy]ethyl ester)